GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers

$479,142
Wenbin Lin · University Of Chicago · R01 · FY2024 · CA

Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases

$479,104
David R Rowley · Baylor College Of Medicine · R01 · FY2022 · CA

Differences in Tumor Biology of Multiple Myeloma

$479,061
Linda B Baughn · Mayo Clinic Rochester · R37 · FY2025 · CA

Roles of hyaluronic acid in cancer stem cell niche

$478,991
Kounosuke Watabe · University Of Mississippi Med Ctr · R01 · FY2014 · CA

Role of Metalloproteinases in Mammary Gland Remodeling

$478,756
Zena Werb · University Of California, San Francisco · R01 · FY2014 · CA

Targeting innate immune pathways in breast cancers with chromosomal instability

$478,720
Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA

Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments

$478,705
Josephine A Taverna · University Of Texas Hlth Science Center · R01 · FY2023 · CA

Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis

$478,632
Javeed Iqbal · University Of Nebraska Medical Center · R01 · FY2022 · CA

Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis

$478,632
Javeed Iqbal · University Of Nebraska Medical Center · R01 · FY2023 · CA

Biological and clinical significance of spatial immune heterogenenity in non-small cell lung cancer

$478,532
Kurt A Schalper · Yale University · R21 · FY2025 · CA

The Roles of Lymphoid Tissue Microenvironments in Guiding the Immune Response

$478,512
Michael Gerner · University Of Washington · R01 · FY2020 · AI

Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma

$478,486
Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

Melanoma: Metabolic Biomarkers of Response to Targeted Therapy

$478,396
Jerry D Glickson · University Of Pennsylvania · R01 · FY2020 · CA

Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy

$478,383
J. Silvio Gutkind · University Of California, San Diego · R01 · FY2018 · DE

Synthetic lethality by targeting the core senescent mechanism in lung cancer.

$478,350
Xiao-Fan Wang · Duke University · R01 · FY2023 · CA

Core--Molecular Genetics

$478,335
University Of Arkansas Med Scis Ltl Rock · P01 · FY2005 · CA

Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies

$478,329
Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies

$478,329
Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Targeting bidirectional signaling in lung stroma and cancer cells

$478,243
Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA

TME Administrative Core

$478,231
Paul R Lockman · West Virginia University · P20 · FY2023 · GM

Collagen Sequence Variants in Racial Disparities of Breast Cancer

$478,126
Peggi M Angel · Medical University Of South Carolina · R01 · FY2024 · CA

Dissecting the NRG4 hormonal checkpoint in metabolic liver disease

$478,123
Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2023 · DK

Dissecting the NRG4 hormonal checkpoint in metabolic liver disease

$478,123
Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2022 · DK

NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance

$478,120
Albert Hong-Jae Kim · Washington University · R01 · FY2022 · NS

NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia

$478,114
Denis C Guttridge · Medical University Of South Carolina · R01 · FY2022 · AR